Stock Price
1.53
Daily Change
-0.11 -6.71%
Monthly
20.47%
Yearly
-34.05%
Q3 Forecast
1.63

Tilray reported $-1.78 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q1 Sep/2025 -0.06 -0.06 Oct/02 2025
FY2025Q4 Jun/2025 -1.79 -0.02 -0.06 Jul/28 2025
FY2025Q3 Mar/2025 -1.24 -0.06 -0.16 Apr/08 2025
FY2025Q2 Dec/2024 -0.14 -0.05 -0.09 Jan/10 2025
FY2025Q1 Sep/2024 -0.06 -0.05 -0.14 Oct/10 2024


Financials
Assets USD 4.19B
Cost of Sales USD 149.73M
Current Assets USD 707.34M
Debt USD 351.72M
EBIT USD -42.22M
EBITDA USD -101K
Employees USD 2.65K
Interest Income USD 12.83M
Loan Capital USD 316.63M
Net Income USD -85.34M
Operating Expenses USD 253.17M
Operating Profit USD -42.22M
Pre-Tax Profit USD -83.24M
Sales Revenues USD 308.01M
Stock USD 266.01M
Trade Creditors USD 99.08M
Trade Debtors USD 112.74M

Eps Change Date
Acasti Pharma USD -0.21 0.15 Jun/2025
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
Aurora Cannabis CAD -0.26 0.84 Jun/2025
Avita Medical AUD -0.21 0.05 Dec/2024
Canopy Growth CAD -0.22 0.89 Jun/2025
Cronos Group USD -0.1 0.12 Jun/2025
Dianthus Therapeutics USD -0.88 0.07 Jun/2025
Divis Laboratories Ltd 20.49 4.26 Jun/2025
Ionis Pharmaceuticals USD 0.7 1.63 Jun/2025
IQVIA Holdings USD 2.81 0.11 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Moderna USD -2.13 0.39 Jun/2025
Organigram Holdings CAD -0.05 0.16 Jun/2025
Organon & Co USD 1 0.02 Jun/2025
Revvity USD 1.18 0.17 Jun/2025
Tectonic Therapeutic USD -1.07 0.23 Jun/2025
Tilray USD -1.78 0.54 Jun/2025
Viatris USD 0.62 0.12 Jun/2025
Xeris Pharmaceuticals USD -0.01 0.02 Jun/2025